CellCarta (formerly known as Caprion-HistoGeneX) is a contract research organization (CRO) with expertise in immune monitoring, proteomics, and biomarker research.
Cantabio Pharmaceuticals Inc. is a biotechnology company focusing on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson’s disease (PD), Alzheimer’s disease (AD) and other related neurodegenerative diseases.
TME Pharma (formerly known as NOXXON Pharma) is a clinical-stage biopharmaceutical company that focuses on the development of proprietary therapeutics for the treatment of cancer.